Ajanta Pharma (AJANTPHARM) Share Price falls 2.95% as Healthcare stock stays in focus
- September 1, 2026
- Posted by: Kunal Singla
- Category: News
Ajanta Pharma Share Price fell today, with the stock last traded at Rs 3,510.9, down 2.95% from the previous close, and the company’s market capitalisation stood at Rs 44,460.42 crore. As of 01 October 2026 at 9:23:37 AM IST, Ajanta Pharma Share Price was trading lower in a move that keeps Ajanta Pharma Share Price Today, Ajanta Pharma Stock News and Ajanta Pharma Share Price Fall in focus. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the move relevant as a verified price action event rather than a story built on speculation. For readers following Ajanta Pharma Share Price Live, the key question is how the decline compares with the company’s valuation, profitability and Healthcare sector peers.
Ajanta Pharma Share Price also matters because the stock is a Large Cap company within Pharmaceuticals & Drugs, and its latest trade places the move firmly inside a broader fundamental and sector discussion. According to latest Univest figures, the opening level, day range and valuation ratios help frame why Ajanta Pharma Share Price Today is drawing attention.
Ajanta Pharma (AJANTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,510.9 |
| Previous Close | Rs 3,617.45 |
| Today's Move | -Rs 106.55 (-2.95%) |
| Open | Rs 3,593.75 |
| High | Rs 3,593.75 |
| Low | Rs 3,494 |
| Market Capitalisation | Rs 44,460.42 crore |
| Market Cap Category | Large Cap |
Ajanta Pharma Share Price today showed a clear intraday decline. The stock opened at Rs 3,593.75, touched a high of Rs 3,593.75 and a low of Rs 3,494, before trading at Rs 3,510.9. Compared with the previous close of Rs 3,617.45, the share price fall was Rs 106.55 or 2.95%. The gap between the day’s high and low shows that Ajanta Pharma Share Price moved within a relatively tight band around the opening level, but the final trade stayed below the prior close.
With market capitalisation of Rs 44,460.42 crore, Ajanta Pharma Share Price remains a Large Cap name, which makes today’s move important for investors who track Ajanta Pharma Stock News, Ajanta Pharma Share Price Update and Ajanta Pharma Stock Performance. According to Univest data, the latest session change is the latest session move, and the cumulative streak change percent is also -2.95% since the base price of Rs 3,617.45. The price event is confirmed, but no company-specific catalyst is established. That shifts the focus to Ajanta Pharma Share Price today and the underlying fundamental profile.
Ajanta Pharma (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 44,460.42 crore |
| P/E Ratio | 39.83x |
| P/B Ratio | 9.3x |
| ROE | 25.42% |
| ROCE | 32.67% |
| EPS | Rs 90.82 |
| Book Value Per Share | Rs 388.77 |
| Dividend Yield | 0.77% |
Ajanta Pharma (AJANTPHARM) fundamental metrics show P/E 39.83x, P/B 9.3x, ROE 25.42%, ROCE 32.67%. These ratios show where the company stands today and are not a call to buy or sell.
Ajanta Pharma has a market capitalisation of Rs 44,460.42 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 39.83x, P/B at 9.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.42% and ROCE of 32.67%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 90.82, book value per share of Rs 388.77, dividend yield of 0.77%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.02x, median ROE of 11.7%, median ROCE of 13.61%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 39.83x |
| Benchmark Median P/E | 32.02x |
| Benchmark Average P/E | 49.17x |
| Benchmark P/E Range | 3.4x to 688.17x |
| Company P/B Ratio | 9.3x |
| Benchmark Median P/B | 2.94x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 25.42% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 32.67% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 44,460.42 crore |
| Benchmark Median Market Cap | Rs 770.9 crore |
| Benchmark Average Market Cap | Rs 14,358.25 crore |
Ajanta Pharma (AJANTPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Ajanta Pharma (AJANTPHARM) has a P/E ratio of 39.83x, which is above the benchmark median of 32.02x, a difference of +24.39%. A P/E difference of this kind is a reference point rather than a recommendation.
Ajanta Pharma (AJANTPHARM) has a ROE of 25.42%, which is above the benchmark median of 11.7%, a difference of +117.26%. Ajanta Pharma (AJANTPHARM) has a ROCE of 32.67%, which is above the benchmark median of 13.61%, a difference of +140.04%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,46,276.3 | 36.1 | 5.05 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,51,531.48 | 84.24 | 13.95 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,86,956.51 | 83.74 | 20.35 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,221.66 | 25.71 | 4.3 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,728.51 | 32.36 | 3.1 | 11.83 | 16 |
Ajanta Pharma (AJANTPHARM) has a P/E ratio of 39.83x compared with the displayed peer median of 36.1x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.42% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 32.67% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ajanta Pharma (AJANTPHARM) has a market capitalisation of Rs 44,460.42 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma
- Ajanta Pharma Share Price fell 2.95% in the latest trade, which puts the day’s price action directly in focus.
- The stock trades at P/E 39.83 and P/B 9.3, so Ajanta Pharma Fundamental Analysis remains important.
- ROE of 25.42% and ROCE of 32.67% keep Ajanta Pharma Share Price relevant in peer comparison.
- Market cap of Rs 44,460.42 crore places Ajanta Pharma Share Price in the Large Cap bracket.
- According to Univest data, no company-specific catalyst is established, so today’s decline is best read through price and valuation context.
About Ajanta Pharma
Ajanta Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s positioning in Ajanta Pharma Share Price updates is tied to its scale, profitability and market value rather than a single-day move. In broad terms, Ajanta Pharma Share Price reflects a business that is tracked for its financial ratios, earnings profile and industry standing within the Indian pharma space.
For readers following Ajanta Pharma Share Price News, the company’s identity is straightforward: it is a Large Cap pharmaceuticals company, and its stock is watched alongside sector peers such as Sun Pharma, Cipla, Lupin, Dr. Reddy’s and others. That makes Ajanta Pharma Share Price useful to track whenever Healthcare stock performance becomes a market theme.
Track Ajanta Pharma Share Price on Univest
Use Ajanta Pharma (AJANTPHARM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Ajanta Pharma Share Price on Univest for live price updates, key valuation ratios, market capitalisation, 52-week levels and broader market insights. Ajanta Pharma Share Price Today is also available alongside Ajanta Pharma Stock News, Ajanta Pharma Share Price Live and Ajanta Pharma Stock Analysis so readers can follow the stock in one place.
Univest also helps users compare Ajanta Pharma Share Price with peer valuation, sector context and company fundamentals without mixing in unsupported commentary. That makes it easier to review Ajanta Pharma Share Price Update and Ajanta Pharma Latest News as fresh market data arrives.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Ajanta Pharma Share Price falling today?
Ans. Ajanta Pharma Share Price fell 2.95% to Rs 3,510.9 from the previous close of Rs 3,617.45. The price move is confirmed in Univest data; a company-specific reason has not been established.
What is Ajanta Pharma Share Price today?
Ans. Ajanta Pharma Share Price today was Rs 3,510.9, down Rs 106.55 from the previous close. The stock opened at Rs 3,593.75 and traded between Rs 3,494 and Rs 3,593.75 in the latest move.
What is Ajanta Pharma market capitalisation?
Ans. Ajanta Pharma Share Price is backed by a market capitalisation of Rs 44,460.42 crore. That places the company in the Large Cap category and gives useful context for comparing it with Healthcare peers.
How does Ajanta Pharma compare with sector valuation?
Ans. Ajanta Pharma Share Price trades at a P/E of 39.83, above the industry median of 32.02 and below the industry average of 49.17. Its P/B of 9.3 is also above the benchmark median of 2.94.
Is Ajanta Pharma profitable on return ratios?
Ans. Ajanta Pharma Share Price is supported by ROE of 25.42% and ROCE of 32.67%. Both are above the Healthcare industry medians, which helps explain why investors still follow the stock closely.
What are Ajanta Pharma EPS and book value?
Ans. Ajanta Pharma Share Price is linked to EPS of Rs 90.82 and book value per share of Rs 388.77. EPS shows earnings attributable to each share, while book value shows accounting net worth per share.
How does Ajanta Pharma compare with peers?
Ans. Ajanta Pharma Share Price has a smaller market cap than Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals, but its ROCE of 32.67% is higher than the peers shown here. That makes the stock notable in peer comparison.
Should investors track Ajanta Pharma Share Price on Univest?
Ans. Ajanta Pharma Share Price can be tracked on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels and company insights. That gives a single place to follow Ajanta Pharma Stock News and fundamentals.
